Related references
Note: Only part of the references are listed.StellarPGx: A Nextflow Pipeline for Calling Star Alleles in Cytochrome P450 Genes
David Twesigomwe et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
The Thai reference exome (T-REx) variant database
Vorasuk Shotelersuk et al.
CLINICAL GENETICS (2021)
Cytochrome P450 4B1 (CYP4B1) as a target in cancer treatment
S. Y. M. Lim et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2020)
The association between NAT2 acetylator status and adverse drug reactions of sulfasalazine: a systematic review and meta-analysis
Jeong Yee et al.
SCIENTIFIC REPORTS (2020)
Phenotype prediction and characterization of 25 pharmacogenes in Thais from whole genome sequencing for clinical implementation
John Mauleekoonphairoj et al.
SCIENTIFIC REPORTS (2020)
Stargazer: a software tool for calling star alleles from nextgeneration sequencing data using CYP2D6 as a model
Seung-been Lee et al.
GENETICS IN MEDICINE (2019)
Clinical Pharmacogenetics Implementation Consortium Guideline for Cytochrome P450 (CYP)2D6 Genotype and Atomoxetine Therapy
Jacob T. Brown et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Calling Star Alleles With Stargazer in 28 Pharmacogenes With Whole Genome Sequences
Seung-been Lee et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
CYP3A5 and CYP3A7 genetic polymorphisms affect tacrolimus concentration in pediatric patients with nephrotic range proteinuria
Hongxia Liu et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Repaglinide-irbesartan drug interaction: effects of SLCO1B1 polymorphism on repaglinide pharmacokinetics and pharmacodynamics in Chinese population
Qi Pei et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2018)
NAT2 ultra-slow acetylator and risk of anti-tuberculosis drug-induced liver injury: a genotype-based meta-analysis
Supharat Suvichapanich et al.
PHARMACOGENETICS AND GENOMICS (2018)
Allelic decomposition and exact genotyping of highly polymorphic and structurally variant genes
Ibrahim Numanagic et al.
NATURE COMMUNICATIONS (2018)
Frequency of CYP2D6 Alleles Including Structural Variants in the United States
Andria L. Del Tredici et al.
FRONTIERS IN PHARMACOLOGY (2018)
A One-Penny Imputed Genome from Next-Generation Reference Panels
Brian L. Browning et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2018)
Relationship of SULT1A1 copy number variation with estrogen metabolism and human health
Jixia Liu et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2017)
Worldwide Distribution of Cytochrome P450 Alleles: A Meta-analysis of Population-scale Sequencing Projects
Y. Zhou et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Constellation: a tool for rapid, automated phenotype assignment of a highly polymorphic pharmacogene, CYP2D6, from whole-genome sequences
Greyson P. Twist et al.
NPJ GENOMIC MEDICINE (2016)
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing
K. A. Birdwell et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors
J. K. Hicks et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy: 2014 Update
L. B. Ramsey et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Rasburicase Therapy in the Context of G6PD Deficiency Genotype
M. V. Relling et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
Interethnic variability of CYP2D6 alleles and of predicted and measured metabolic phenotypes across world populations
Adrian LLerena et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2014)
Comprehensive Variant Screening of the UGT Gene Family
Jason Yongha Kim et al.
YONSEI MEDICAL JOURNAL (2014)
Genetics and genomics in Thailand: challenges and opportunities
Vorasuk Shotelersuk et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2014)
Impact of ABCC2, ABCG2 and SLCO1B1 Polymorphisms on the Pharmacokinetics of Pitavastatin in Humans
Eun Sil Oh et al.
DRUG METABOLISM AND PHARMACOKINETICS (2013)
Effect of the P450 oxidoreductase *28 polymorphism on the pharmacokinetics of tacrolimus in Chinese healthy male volunteers
Jing-Jing Zhang et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Phase II study of S-1 combined with oxaliplatin as therapy for patients with metastatic biliary tract cancer: influence of the CYP2A6 polymorphism on pharmacokinetics and clinical activity
K. -P Kim et al.
BRITISH JOURNAL OF CANCER (2011)
Population pharmacokinetic analysis of letrozole in Japanese postmenopausal women
Hiromi Tanii et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2011)
A framework for variation discovery and genotyping using next-generation DNA sequencing data
Mark A. DePristo et al.
NATURE GENETICS (2011)
Organic Anion Transporting Polypeptide 1B1: a Genetically Polymorphic Transporter of Major Importance for Hepatic Drug Uptake
Mikko Niemi et al.
PHARMACOLOGICAL REVIEWS (2011)
The Role of Organic Anion-Transporting Polypeptides and Their Common Genetic Variants in Mycophenolic Acid Pharmacokinetics
N. Picard et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Genetic polymorphism in the conjugating enzyme UGT1A1 and the risk of head and neck cancer
Martin Lacko et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Fast and accurate short read alignment with Burrows-Wheeler transform
Heng Li et al.
BIOINFORMATICS (2009)
UGT1A1*6 polymorphism is most predictive of severe neutropenia induced by irinotecan in Japanese cancer patients
Masahide Onoue et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2009)
Quantitative Population Pharmacokinetic Analysis of Pravastatin Using an Enterohepatic Circulation Model Combined With Pharmacogenomic Information on SLCO1B1 and ABCC2 Polymorphisms
Takafumi Ide et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Very important pharmacogene summary: sulfotransferase 1A1
Michelle Hildebrandt et al.
PHARMACOGENETICS AND GENOMICS (2009)
CYP2A6 and the plasma level of 5-chloro-2, 4-dihydroxypyridine are determinants of the pharmacokinetic variability of tegafur and 5-fluorouracil, respectively, in Japanese patients with cancer given S-1
Ken-ichi Fujita et al.
CANCER SCIENCE (2008)
Serum bilirubin levels, UGT1A1 polymorphisms and risk for coronary artery disease
Arno Lingenhel et al.
EXPERIMENTAL GERONTOLOGY (2008)
Possible relationship between the risk of japanese bladder cancer cases and the CYP4B1 genotype
Takamitsu Sasaki et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2008)
Pharmacokinetic interaction between pravastatin and olmesartan in relation to SLCO1B1 polymorphism
Suttasinee Suwannakul et al.
JOURNAL OF HUMAN GENETICS (2008)
Influence of OATP1B1 genotype on the pharmacokinetics of rosuvastatin in Koreans
J. H. Choi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering
Sharon R. Browning et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Role of UGT1A1*6, UGT1A1*28 and ABCG2 c.421C>A polymorphisms in irinotecan-induced neutropenia in Asian cancer patients
Srinivasa Rao Jada et al.
CANCER SCIENCE (2007)
Molecular analysis of the CYP2F1 gene: Identification of a frequent non-functional allelic variant
Gilles Tournel et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2007)
Human SULT1A1 gene:: copy number differences and functional implications
Scott J. Hebbring et al.
HUMAN MOLECULAR GENETICS (2007)
X-linked G6PD deficiency protects hemizygous males but not heterozygous females against severe malaria
Aldiouma Guindo et al.
PLOS MEDICINE (2007)
Association of the diplotype configuration at the N-acetyltransferase 2 gene with adverse events with co-trimoxazole in Japanese patients with systemic lupus erythematosus
Makoto Soejima et al.
ARTHRITIS RESEARCH & THERAPY (2007)
Relationship between hyperbilirubinaemia and UDP-glucuronosyltransferase 1A1 (UGT1A1) polymorphism in adult HIV-infected Thai patients treated with indinavir
Mark A. Boyd et al.
PHARMACOGENETICS AND GENOMICS (2006)
Organic anion transporting polypeptide 1B1 activity classified by SLCO1B1 genotype influences atrasentan pharmacokinetics
DA Katz et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Comprehensive evaluation of variability in nicotine metabolism and CYP2A6 polymorphic alleles in four ethnic populations
Miki Nakajima et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
CYP4B1: An enigmatic P450 at the interface between xenobiotic and endobiotic metabolism
Brian R. Baer et al.
DRUG METABOLISM REVIEWS (2006)
In vivo evaluation of coumarin and nicotine as probe drugs to predict the metabolic capacity of CYP2A6 due to genetic polymorphism in Thais
Sompop Peamkrasatam et al.
DRUG METABOLISM AND PHARMACOKINETICS (2006)
Link between colorectal cancer and polymorphisms in the uridine-diphosphoglucuronosyltransferase 1A7 and 1A1 genes
Kung-Sheng Tang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
The sequence and analysis of duplication-rich human chromosome 16
J Martin et al.
NATURE (2004)
Impact of cytochrome P450 3A5 genetic polymorphism on tacrolimus doses and concentration-to-dose ratio in renal transplant recipients
E Thervet et al.
TRANSPLANTATION (2003)
A review and assessment of potential sources of ethnic differences in drug responsiveness
TD Bjornsson et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Genetic polymorphisms in human CYP2A6 gene causing impaired nicotine metabolism
R Yoshida et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Controlling the false discovery rate in behavior genetics research
Y Benjamini et al.
BEHAVIOURAL BRAIN RESEARCH (2001)
Sulfation pharmacogenetics:: SULT1A1 and SULT1A2 allele frequencies in Caucasian, Chinese and African-American subjects
EJ Carlini et al.
PHARMACOGENETICS (2001)
Omeprazole and CYP2C19 polymorphism:: effects of long-term treatment on gastrin, pepsinogen I, and chromogranin A in patients with acid related disorders
M Sagar et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2000)
Share Paper
